Lodi, A., Tiziani, S., Khanim, F. L., Günther, U. L., Viant, M. R., Morgan, G. J., . . . Drayson, M. T. (2013). Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples from Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active Disease. PloS one, 8(2), e56422. https://doi.org/10.1371/journal.pone.0056422
Citace podle Chicago (17th ed.)Lodi, Alessia, Stefano Tiziani, Farhat L. Khanim, Ulrich L. Günther, Mark R. Viant, Gareth J. Morgan, Christopher M. Bunce, a Mark T. Drayson. "Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples from Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active Disease." PloS One 8, no. 2 (2013): e56422. https://doi.org/10.1371/journal.pone.0056422.
Citace podle MLA (9th ed.)Lodi, Alessia, et al. "Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples from Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active Disease." PloS One, vol. 8, no. 2, 2013, p. e56422, https://doi.org/10.1371/journal.pone.0056422.